A financial perspective on the topical treatment of onychomycosis

J Am Acad Dermatol. 2016 Jul;75(1):e37. doi: 10.1016/j.jaad.2015.11.053.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Antifungal Agents / economics*
  • Antifungal Agents / therapeutic use*
  • Boron Compounds / economics
  • Boron Compounds / therapeutic use*
  • Bridged Bicyclo Compounds, Heterocyclic / economics
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use*
  • Cost-Benefit Analysis
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Costs*
  • Female
  • Follow-Up Studies
  • Foot Dermatoses / diagnosis
  • Foot Dermatoses / drug therapy
  • Humans
  • Male
  • Onychomycosis / diagnosis
  • Onychomycosis / drug therapy*
  • Risk Assessment
  • Treatment Outcome
  • Triazoles / economics
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Boron Compounds
  • Bridged Bicyclo Compounds, Heterocyclic
  • Triazoles
  • efinaconazole
  • tavaborole